| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| R&D Expense | $2.7M | -35.0% |
| SG&A Expense | $24.6M | +60.3% |
| Operating Income | -$81.6M | -111.7% |
| Net Income | -$88.4M | -122.8% |
| EPS (Basic) | -$0.91 | -28.2% |
| EPS (Diluted) | -$0.91 | -28.2% |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $220K | -88.2% |
| Current Assets | $2.0M | -22.1% |
| Total Assets | $163.1M | +179.8% |
| Current Liabilities | $30.3M | +175.0% |
| Total Liabilities | $31.2M | +164.0% |
| Stockholders' Equity | $132.0M | +183.8% |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$11.0M | +6.8% |
| Capital Expenditures | $70K | +136.5% |
| Investing Cash Flow | -$1.3M | -4132.5% |
| Financing Cash Flow | $10.5M | +132.9% |
| Free Cash Flow | -$11.0M | +6.5% |